Drexel University College of Medicine

Diseases and Conditions

Pancreatic islet cell tumor

Definition

A pancreatic islet cell tumor is a rare tumor of the pancreas that starts from a type of cell called the islet cell.

Alternative Names

Islet cell tumors; Islet of Langerhans tumor; Neuroendocrine tumors

Causes, incidence, and risk factors

In the normal pancreas, cells called islet cells produce hormones that regulate a variety of bodily functions, such as blood sugar level and the production of stomach acid.

Tumors that arise from islet cells of the pancreas can also produce a variety of hormones, though some do not.

Although islet cells produce many different hormones, most tumors release only one hormone that leads to specific symptoms. Pancreatic islet cell tumors can be noncancerous (benign) or cancerous (malignant).

Islet cell tumors include:

• Gastrinomas (Zollinger-Ellison syndrome)
• Glucagonomas
• Insulinomas

A family history of multiple endocrine neoplasia, type I (MEN I) is a risk factor for islet cell tumors.

Symptoms

Symptoms are caused by the hormone the tumor is producing.

For example, insulinomas produce the hormone insulin, which helps the body lower blood sugar levels. Symptoms may include:

• Feeling tired or weak
• Shaking or sweating
• Headache
• Hunger
• Nervousness, anxiety, or feeling irritable
• Unclear thinking or feeling uneasy
• Double or blurry vision
• Fast or pounding heartbeat

If your blood sugar gets too low, you may faint, have a seizure, or even go into a coma.

Gastrinomas make the hormone gastrin, which helps the body manage stomach acid. Symptoms may include:

• Abdominal pain
• Diarrhea
• Ulcers in the stomach and small bowel
• Vomiting blood (occasionally)

Glucagonomas make the hormone glucagon, which helps the body raise blood sugar levels. Symptoms can include:

• Diabetes (present in most of the patients)
• Inflamed mouth and tongue
• Crusty or scaly skin rash on the face, abdomen, buttocks, or feet - may be filled with clear fluid or pus

Signs and tests

Blood tests may vary depending upon the symptoms, but may include:

• Fasting glucose level
• Gastrin level
• Glucose tolerance test
• Secretin stimulation test for pancreas
• Blood glucagon level
• Blood insulin C-peptide
• Blood insulin level

The following imaging tests may be performed:

• Abdominal CT scan
• Abdominal ultrasound
• Endoscopic ultrasound
• MRI of abdomen

Other tests that may be done include:

Sampling the vein drainage of segments of the pancreas

Occasionally, surgery is needed to diagnose and treat this condition. During this procedure, the surgeon feels the pancreas and may use ultrasound probes.

Treatment

Treatment will depend on the type of tumor and whether the tumor is noncancerous (benign) or cancerous (malignant). Malignant tumors can spread to other organs, grow aggressively, and may not be treatable. Tumors are usually removed with surgery, if possible.

If malignant cancer cells spread (metastasize) to the liver, a portion of the liver may also be removed, if possible. If the cancer is widespread, various forms of chemotherapy may be used to try and shrink the tumors.

If the abnormal production of hormones is causing problems, you may receive medications to counteract their effects. For example, with gastrinomas, the overproduction of gastrin leads to too much acid in the stomach. Medications that block acid release can reduce symptoms.

Expectations (prognosis)

You may be cured if the tumors are surgically removed before they have spread to other organs. If tumors are cancerous, chemotherapy may be used, but it usually cannot cure patients.

Life-threatening problems (such as very low blood sugar) can occur due to excess hormone production, or if the cancer spreads throughout the body.

Complications

• Diabetes
• Hormone crises (if the tumor releases certain types of hormones)
• Severe low blood sugar (from insulinomas)
• Severe ulcers in the stomach and small intestine (from gastrinomas)
• Spread of the tumor to the liver

Calling your health care provider

Call your health care provider if you develop symptoms of these tumors, especially if you have a family history of MEN I.

Prevention

There is no known prevention for these tumors.

References

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. National Comprehensive Cancer Network; 2009. Version 2.2009.

Jensen RT. Pancreatic endocrine tumors. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 205.

Physician Reference

International Classification of Diseases, 9^th Revision (ICD9)

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only - they do not constitute endorsements of those other sites. Copyright 2009 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.